Immunoassays

The PhoenixDx® SARS-CoV-2 Neutralizing Antibody Test Kit (ELISA) is used for the in vitro qualitative detection of neutralizing antibodies (nAb) against RBD of Novel Coronavirus (SARS-CoV-2) S1 protein in human serum or plasma.

real-time RT-PCR-based diagnostic test for the in vitro qualitative detection and discrimination of SARS-CoV-2, Delta and Omicron.

COVELISA®COVID-19 IgM ELISA is an in-vitro semi-quantitative detection test of human antibodies of the immunoglobulin class IgM directed against SARS-CoV-2.

ENZYME IMMUNOASSAY FOR THE QUANTITATIVE DETERMINATION OF HUMAN BIG ENDOTHELIN-1 IN SERUM, EDTA PLASMA, HEPARIN PLASMA, OR CITRATE PLASMA

ENZYME IMMUNOASSAY FOR THE QUANTITATIVE DETERMINATION OF HUMAN DKK-1 IN SERUM

3rd Generation ENZYME IMMUNOASSAY FOR THE QUANTITATIVE DETERMINATION OF FREE, SOLUBLE, UNCOMPLEXED HUMAN RANKL* IN SERUM OR HEPARIN PLASMA

ELISA FOR THE QUANTITATIVE DETERMINATION OF HUMAN INTACT FGF23 IN EDTA PLASMA, HEPARIN PLASMA, AND CITRATE PLASMA

ENZYME IMMUNOASSAY FOR THE QUANTITATIVE DETERMINATION OF NT-proCNP IN SERUM, EDTA PLASMA, CITRATE PLASMA OR HEPARIN PLASMA.

ENZYME IMMUNOASSAY FOR THE QUALITATIVE OR QUANTITATIVE DETERMINATION OF IgG-ANTIBODIES TO BORRELIA IN PLASMA, SERUM OR CEREBROSPINAL FLUID.

ENZYME IMMUNOASSAY FOR THE QUALITATIVE OR QUANTITATIVE DETERMINATION OF IgM-ANTIBODIES TO BORRELIA IN PLASMA, SERUM OR CEREBROSPINAL FLUID.